The Potential Role of Curcumin as a Regulator of microRNA in Colorectal Cancer: A Systematic Review
Authors:
- 1 February 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in MicroRNA
- Vol. 14 (1) , 42-48
Abstract
Introduction: Curcumin is known as a bioactive component that is found in the rhizomes of Curcuma longa. Curcumin is well known for its chemo-preventive and anticancer properties. However, its anticancer mechanism in colorectal cancer treatment is unclear, and some studies have shown that many microRNAs (miRs) could be potential targets for curcumin in colorectal cancer (CRC) treatment, so there is a need for their integration and clarification. Methods: We systematically searched international databases, including PubMed, Scopus, and Web of Science, until July 2021 by using some relevant keywords. Results: The search resulted in 87 papers, among which there were 18 related articles. Curcumin was found to cause the upregulation of miR-497, miR-200c, miR-200b, miR-409-3p, miR‐34, miR‐126, miR-145, miR-206, miR-491, miR-141, miR-429, miR-101, and miR-15a and the downregulation of miR-21, miR-155, miR‐221, miR‐222, miR-17-5p, miR-130a, miR-27, and miR-20a. Conclusion: The present review study suggests that curcumin may be useful as a novel therapeutic agent for CRC by altering the expression level of miRs.Keywords
This publication has 28 references indexed in Scilit:
- Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancersBiomedicine & Pharmacotherapy, 2021
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cellsMolecular and Cellular Biochemistry, 2020
- Polymersome‐assisted delivery of curcumin: A suitable approach to decrease cancer stemness markers and regulate miRNAs expression in HT29 colorectal cancer cellsPolymers for Advanced Technologies, 2019
- Developments in the anticancer activity of structurally modified curcumin: An up-to-date reviewEuropean Journal of Medicinal Chemistry, 2019
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerInternational Journal of Clinical Oncology, 2019
- The effects of Curcumin on HCT‐116 cells proliferation and apoptosis via the miR‐491/PEG10 pathwayJournal of Cellular Biochemistry, 2018
- Curcumin Promotes Cell Cycle Arrest and Inhibits Survival of Human Renal Cancer Cells by Negative Modulation of the PI3K/AKT Signaling PathwayCell Biochemistry and Biophysics, 2015
- The drug resistance suppression induced by curcuminoids in colon cancer SW‐480 cells is mediated by reactive oxygen species‐induced disruption of the microRNA‐27a‐ZBTB10‐Sp axisMolecular Nutrition & Food Research, 2013
- The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathwayBiochemical Pharmacology, 2012